Overview

Safety Study of BMS-823778 in Subjects With Hypercholesterolemia

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability and pharmacodynamic effects on LDL cholesterol (LDL-C)
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb